TAMPA, Fla., April 1, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of what the Company believes is its largest to date definitive marketing agreement with a leading healthcare solutions provider. This strategic collaboration is designed to scale the reach of MarpaiRx, Marpai's pharmacy benefit management (PBM) services, across a vast network of self-insured employer groups and third-party administrators.

Under the terms of the three-year agreement, the team will leverage its extensive domestic and international affiliate network to promote Marpai's integrated PBM and TPA services. This collaboration directly supports Marpai's stated objective of achieving sustained profitability by providing access to a massive pipeline of potential members.

Strategic Expansion of MarpaiRx

The agreement establishes a "Most Favored Economics" framework, ensuring our clients remain at the forefront of competitive pricing and rebate participation in the PBM sector. The agreement covers a comprehensive suite of services, including:

Pharmacy Benefit Management (PBM): Enhancing clinical outcomes through transparent drug spend management.
Shared Savings Initiatives: A collaborative model where savings from network discounts and manufacturer rebates are shared across stakeholders to drive down the cost of care.
Coordinated Healthcare Solutions: Integration with Marpai's existing TPA, consulting, and technology services.

Leadership Perspectives

"We view the execution of agreement a pivotal moment in the evolution of MarpaiRx," said Mimi Davis, President of MarpaiRx. "By aligning with a partner that shares our commitment to transparency and clinical excellence, we are positioned to deliver our high-performance PBM solutions to a significantly broader audience. We are not just expanding our footprint; we are redefining how employers manage pharmacy spend through itemized drug-spend transparency and innovative pricing models."

Damien Lamendola, CEO of Marpai, added: "We believe this agreement, which is our largest to date, further validates the strength of the MarpaiRx value proposition. It provides us with a potential substantial pipeline to accelerate our growth and reach our goal of positive operating cash flow and profitability. By combining our AI-driven TPA capabilities with this expansive marketing reach, we are creating a unique, integrated healthcare offering that serves the best interests of both plan sponsors and their members."

Commitment to Transparency

In line with Marpai's core values, the agreement mandates full data transparency, including itemized reporting on manufacturer rebates, administrative fees, and drug spend. This ensures that all entities introduced through this partnership benefit from the highest standards of financial integrity and regulatory compliance.

About Marpai, Inc.

Marpai, Inc. (OTCQX:MRAI) is a technology platform company which operates subsidiaries that provide TPA, PBM and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $150 billion TPA sector serving self-funded employer health plans representing over $1.5 trillion in annual claims. Through its Marpai Saves initiative, the Company works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://ir.marpaihealth.com.

Forward-Looking Statement Disclaimer

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward-looking statements when it discusses the potential benefits of the agreement, the belief that the agreement is its largest to date definitive marketing agreement, that the collaboration directly supports its stated objective of achieving sustained profitability by providing access to a massive pipeline of potential members, that the agreement further validates the strength of the MarpaiRx value proposition and the belief that the agreement provides it with a potential substantial pipeline to accelerate growth and reach its goal of positive operating cash flow and profitability. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-inc-secures-major-strategic-marketing-collaboration-to-continue-acceleration-of-marpairx-growth-nationwide-302731537.html

SOURCE Marpai

Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide